Global Paroxetine Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 130

Report ID: 224859

Paroxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder and premenstrual dysphoric disorder. It has also been used in the treatment of hot flashes and night sweats associated with menopause.

According to this study, over the next five years the Paroxetine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Paroxetine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Paroxetine market by product type, application, key manufacturers and key regions and countries.

This study considers the Paroxetine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Depression
Panic disorder
Social anxiety disorder
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Apotex
Sebela Pharmaceuticals
Teva
Mylan
Sun Pharmaceutical
Lupin
Lannett Company
Aurobindo
Jubilant Pharma
Sciecure Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Paroxetine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Paroxetine market by identifying its various subsegments.
Focuses on the key global Paroxetine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paroxetine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Paroxetine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Paroxetine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paroxetine Consumption 2013-2023
2.1.2 Paroxetine Consumption CAGR by Region
2.2 Paroxetine Segment by Type
2.2.1 Paroxetine Hydrochloride Drug
2.2.2 Paroxetine Mesylate Drug
2.3 Paroxetine Consumption by Type
2.3.1 Global Paroxetine Consumption Market Share by Type (2013-2018)
2.3.2 Global Paroxetine Revenue and Market Share by Type (2013-2018)
2.3.3 Global Paroxetine Sale Price by Type (2013-2018)
2.4 Paroxetine Segment by Application
2.4.1 Depression
2.4.2 Panic disorder
2.4.3 Social anxiety disorder
2.4.4 Others
2.5 Paroxetine Consumption by Application
2.5.1 Global Paroxetine Consumption Market Share by Application (2013-2018)
2.5.2 Global Paroxetine Value and Market Share by Application (2013-2018)
2.5.3 Global Paroxetine Sale Price by Application (2013-2018)

3 Global Paroxetine by Players
3.1 Global Paroxetine Sales Market Share by Players
3.1.1 Global Paroxetine Sales by Players (2016-2018)
3.1.2 Global Paroxetine Sales Market Share by Players (2016-2018)
3.2 Global Paroxetine Revenue Market Share by Players
3.2.1 Global Paroxetine Revenue by Players (2016-2018)
3.2.2 Global Paroxetine Revenue Market Share by Players (2016-2018)
3.3 Global Paroxetine Sale Price by Players
3.4 Global Paroxetine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Paroxetine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Paroxetine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Paroxetine by Regions
4.1 Paroxetine by Regions
4.1.1 Global Paroxetine Consumption by Regions
4.1.2 Global Paroxetine Value by Regions
4.2 Americas Paroxetine Consumption Growth
4.3 APAC Paroxetine Consumption Growth
4.4 Europe Paroxetine Consumption Growth
4.5 Middle East & Africa Paroxetine Consumption Growth

5 Americas
5.1 Americas Paroxetine Consumption by Countries
5.1.1 Americas Paroxetine Consumption by Countries (2013-2018)
5.1.2 Americas Paroxetine Value by Countries (2013-2018)
5.2 Americas Paroxetine Consumption by Type
5.3 Americas Paroxetine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Paroxetine Consumption by Countries
6.1.1 APAC Paroxetine Consumption by Countries (2013-2018)
6.1.2 APAC Paroxetine Value by Countries (2013-2018)
6.2 APAC Paroxetine Consumption by Type
6.3 APAC Paroxetine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Paroxetine by Countries
7.1.1 Europe Paroxetine Consumption by Countries (2013-2018)
7.1.2 Europe Paroxetine Value by Countries (2013-2018)
7.2 Europe Paroxetine Consumption by Type
7.3 Europe Paroxetine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Paroxetine by Countries
8.1.1 Middle East & Africa Paroxetine Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Paroxetine Value by Countries (2013-2018)
8.2 Middle East & Africa Paroxetine Consumption by Type
8.3 Middle East & Africa Paroxetine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Paroxetine Distributors
10.3 Paroxetine Customer

11 Global Paroxetine Market Forecast
11.1 Global Paroxetine Consumption Forecast (2018-2023)
11.2 Global Paroxetine Forecast by Regions
11.2.1 Global Paroxetine Forecast by Regions (2018-2023)
11.2.2 Global Paroxetine Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Paroxetine Forecast by Type
11.8 Global Paroxetine Forecast by Application

12 Key Players Analysis
12.1 Apotex
12.1.1 Company Details
12.1.2 Paroxetine Product Offered
12.1.3 Apotex Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Apotex News
12.2 Sebela Pharmaceuticals
12.2.1 Company Details
12.2.2 Paroxetine Product Offered
12.2.3 Sebela Pharmaceuticals Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sebela Pharmaceuticals News
12.3 Teva
12.3.1 Company Details
12.3.2 Paroxetine Product Offered
12.3.3 Teva Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Mylan
12.4.1 Company Details
12.4.2 Paroxetine Product Offered
12.4.3 Mylan Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Sun Pharmaceutical
12.5.1 Company Details
12.5.2 Paroxetine Product Offered
12.5.3 Sun Pharmaceutical Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Sun Pharmaceutical News
12.6 Lupin
12.6.1 Company Details
12.6.2 Paroxetine Product Offered
12.6.3 Lupin Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Lupin News
12.7 Lannett Company
12.7.1 Company Details
12.7.2 Paroxetine Product Offered
12.7.3 Lannett Company Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Lannett Company News
12.8 Aurobindo
12.8.1 Company Details
12.8.2 Paroxetine Product Offered
12.8.3 Aurobindo Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Aurobindo News
12.9 Jubilant Pharma
12.9.1 Company Details
12.9.2 Paroxetine Product Offered
12.9.3 Jubilant Pharma Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Jubilant Pharma News
12.10 Sciecure Pharma
12.10.1 Company Details
12.10.2 Paroxetine Product Offered
12.10.3 Sciecure Pharma Paroxetine Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Sciecure Pharma News

13 Research Findings and Conclusion